Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.

To improve plasma glucose control, we administered insulin via the subcutaneous route in seven ambulatory patients with juvenile diabetes (12 to 17 years of age), using a portable infusion pump at a basal rate with pulse-dose increments before meals. After two to four days, the mean plasma glucose (+/- 1 S.E.) of 94 +/- 5 mg per deciliter was markedly lower than when insulin was given by conventional methods in the patients' usual dose (243 +/- 28, P less than 0.01) or in a total dose equivalent to that administered with the pump (150 +/- 15, P less than 0.01). Maximal fluctuations in plasma glucose were also 50 to 150 mg per deciliter below those observed with conventional treatment (P less than 0.001). Glycosuria was eliminated in six of seven patients during pump treatment. None of the subjects had hypoglycemia. These results demonstrate that plasma glucose can be lowered to normal in ambulatory patients with brittle juvenile diabetes using a portable, subcutaneous insulin infusion system for two to four days. The feasibility and value of the long-term application of this technic need exploration.

[1]  N. Freinkel,et al.  Control and Diabetes , 1976 .

[2]  H. Ohgawara,et al.  Levels of Pancreatic Glucagon, Insulin and Glucose during Twenty-Four Hours of the Day in Normal Subjects , 1975 .

[3]  J. Roth,et al.  Control of blood glucose and diabetic vascular disease. , 1977, The New England journal of medicine.

[4]  A. Huggett,et al.  Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose. , 1957, Lancet.

[5]  S. Tarui,et al.  Studies on the Etiology of “Brittle Diabetes”: Relationship Between Diabetic Instability and Insulinogenic Reserve , 1977, Diabetes.

[6]  F. Ingelfinger Debatees on diabetes. , 1977, The New England journal of medicine.

[7]  A H Clemens,et al.  The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). , 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[8]  H Keen,et al.  Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. , 1978, British medical journal.

[9]  S. Genuth Plasma insulin and glucose profiles in normal, obese, and diabetic persons. , 1973, Annals of internal medicine.

[10]  W Zingg,et al.  Clinical Control of Diabetes by the Artificial Pancreas , 1974, Diabetes.

[11]  E. Cerasi,et al.  Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus. , 1972, The Journal of clinical investigation.

[12]  W. F. Taylor,et al.  Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability , 1970, Diabetes.

[13]  J. Schlichtkrull,et al.  [M-VALUE, AN INDEX FOR BLOOD SUGAR CONTROL IN DIABETICS]. , 1964, Ugeskrift for laeger.

[14]  G D Molnar,et al.  Plasma immunoreactive insulin patterns in insulin-treated diabetics. Studies during continuous blood glucose monitoring. , 1972, Mayo Clinic proceedings.

[15]  R. Sherwin,et al.  Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. , 1978, The Journal of clinical endocrinology and metabolism.